These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4058995

  • 1. Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding.
    Le Guennec JC, Billon B, Paré C.
    Pediatrics; 1985 Nov; 76(5):834-40. PubMed ID: 4058995
    [Abstract] [Full Text] [Related]

  • 2. Delay in caffeine elimination in breast-fed infants.
    Le Guennec JC, Billon B.
    Pediatrics; 1987 Feb; 79(2):264-8. PubMed ID: 3808800
    [Abstract] [Full Text] [Related]

  • 3. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A.
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [Abstract] [Full Text] [Related]

  • 4. Effect of caffeine on pneumogram and apnoea of infancy.
    Anwar M, Mondestin H, Mojica N, Novo R, Graff M, Hiatt M, Hegyi T.
    Arch Dis Child; 1986 Sep; 61(9):891-5. PubMed ID: 3767418
    [Abstract] [Full Text] [Related]

  • 5. Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
    Larsen PB, Brendstrup L, Skov L, Flachs H.
    Acta Paediatr; 1995 Apr; 84(4):360-4. PubMed ID: 7795341
    [Abstract] [Full Text] [Related]

  • 6. Alterations in theophylline metabolism during the first year of life.
    Kraus DM, Fischer JH, Reitz SJ, Kecskes SA, Yeh TF, McCulloch KM, Tung EC, Cwik MJ.
    Clin Pharmacol Ther; 1993 Oct; 54(4):351-9. PubMed ID: 8222476
    [Abstract] [Full Text] [Related]

  • 7. When to start and stop caffeine and why respiratory status matters.
    Davis PG.
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101175. PubMed ID: 33144042
    [Abstract] [Full Text] [Related]

  • 8. Caffeine Administration to Prevent Apnea in Very Premature Infants.
    Armanian AM, Iranpour R, Faghihian E, Salehimehr N.
    Pediatr Neonatol; 2016 Oct; 57(5):408-412. PubMed ID: 26976495
    [Abstract] [Full Text] [Related]

  • 9. Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
    Vatlach S, Arand J, Engel C, Poets CF.
    Neonatology; 2014 Oct; 105(2):108-11. PubMed ID: 24335098
    [Abstract] [Full Text] [Related]

  • 10. Apnea of prematurity and caffeine pharmacokinetics: potential impact on hospital discharge.
    Doyle J, Davidson D, Katz S, Varela M, Demeglio D, DeCristofaro J.
    J Perinatol; 2016 Feb; 36(2):141-4. PubMed ID: 26562367
    [Abstract] [Full Text] [Related]

  • 11. Serum caffeine concentrations in preterm neonates.
    Leon AE, Michienzi K, Ma CX, Hutchison AA.
    Am J Perinatol; 2007 Jan; 24(1):39-47. PubMed ID: 17195151
    [Abstract] [Full Text] [Related]

  • 12. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M, Bacopoulou F, Markantonis SL.
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [Abstract] [Full Text] [Related]

  • 13. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study.
    Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA.
    Pharmacotherapy; 2000 Jun; 20(6):644-52. PubMed ID: 10853619
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of percutaneous caffeine in the treatment of apnea in the premature infant].
    Morisot C, Simoens C, Trublin F, Lhermitte M, Gremillet C, Robert MH, Lequien P.
    Arch Fr Pediatr; 1990 Mar; 47(3):221-4. PubMed ID: 2344252
    [Abstract] [Full Text] [Related]

  • 15. [Caffeine citrate utilization for treatment of apnea in French neonatal units].
    Ducrocq S, Biran-Mucignat V, Lebas F, Baudon JJ, Gold F.
    Arch Pediatr; 2006 Oct; 13(10):1305-8. PubMed ID: 16872813
    [Abstract] [Full Text] [Related]

  • 16. Developmental changes of caffeine elimination in infancy.
    Pons G, Carrier O, Richard MO, Rey E, d'Athis P, Moran C, Badoual J, Olive G.
    Dev Pharmacol Ther; 1988 Oct; 11(5):258-64. PubMed ID: 3191817
    [Abstract] [Full Text] [Related]

  • 17. Caffeine citrate in the NICU.
    Flood E.
    Neonatal Netw; 1989 Apr; 7(5):37-9. PubMed ID: 2704353
    [Abstract] [Full Text] [Related]

  • 18. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y, Tian X, Liu G.
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [Abstract] [Full Text] [Related]

  • 19. Developmental aspects of percutaneous caffeine absorption in premature infants.
    Amato M, Hüppi P, Isenschmid M, Schneider H.
    Am J Perinatol; 1992 Jan; 9(5-6):431-4. PubMed ID: 1418150
    [Abstract] [Full Text] [Related]

  • 20. Aminophylline versus caffeine citrate..
    Duc G, Bucher HU.
    Acta Paediatr; 1995 Oct; 84(10):1210; author reply 1099. PubMed ID: 8563242
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.